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ABSTRACT 
Objective: This study was conducted to find out the effect of obesity on immune cells activity and some biochemical markers in women. 
Methods: The experimentation is carried out on 30 voluntary individuals were divided into two groups; 15 women with obesity (Body Mass 
Index [BMI]>30) were selected, On the other hand, we took 15 witnesses (BMI<30). All the volunteers were subjected to estimate the lipid profile, 
biochemical, and hematological parameters. 
Results: Results obtained show that there was a significant increase of blood glucose (p<0.05), triglyceride (p<0.05) and uric acid (p<0.001) and no 
significant change of other biochemical markers in obese people’s group when compared to the control subjects. In addition, the hematological results 
demonstrated that there was a significant decrease (p<0.05) of lymphocytes, hemoglobin, hematocrit, and mean corpuscular volume levels (p<0.01) 
in women with obesity compared to the controls. 
Conclusion: Our study reveals that the obesity may be induce the sever alteration in lipid profile which cause the cardiovascular risk for this 
population. In addition, the obesity causes a remarkable change in some biochemical markers and blood constituent’s anemia or other metabolic 
disorder in the body.
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INTRODUCTION 
“Globesity” is a word used by the World Health Organization (WHO) 
to describe the global epidemic of overweight and obesity, this latter 
considered like one of the most important health problems in the many 
countries [1]. Obesity is the convergence of environmental, genetic, 
and human behavior factors, and it may also be the result of an energy 
imbalance in the body [2]. Where the degrees of obesity appear on 
the person if body mass index (BMI) >30, this indicator is calculated 
by dividing the weight in kilograms by the square of the height in 
meters [3]. Obesity and overweight have been linked to various health 
disorders, including breast cancer [4]. Furthermore, the latest studies 
related to Coronavirus disease-19 have shown that diabetes is a major 
risk factor for developing disease symptoms in this group [5]. Hebce, 
obesity has a share in the evolution of the virus and also considered 
like cause of cancer, this latter is the second cause of death in the world 
after cardiovascular disease [6] and because it occurs with depression 
frequently [7]. It is also considered alongside metabolic diseases, 
diabetes, and all conditions that are characterized by abdominal fat, are 
well-recognized risk factors for sexual dysfunction in both sexes [8]. 
The number of people in the world who are obese or overweight 
is estimated at more than 2.1 billion, which is considered one of the 
most important causes of death in the world, with an annual rate of 
more than 3.4 million deaths [9]. We can take some possible controls 
for obesity such as: Physical activity, A reduction in food intake alone 
is seldom effective in reduce of weight, and unless accompanied by 
some daily physical activities to increase energy expenditure [10]. 
Furthermore, the role of aqueous plant extract of P. olercea was reached 
3 years before the current time, in reducing the levels of fat and sugar in 
the blood that is why it plays an important role against the development 
of obesity [11]. The many effects of obesity on human health prompted 
us to complete a study that aimed at evaluate the effect of obesity on 




Ethical approval was requested and approved by the Ethics Committee 
of the Department of Cellular and Molecular Biology, Faculty of Natural 
Sciences and Life, University of El Oued. 
Study subject
The study was conducted on 30 volunteers, whose ages ranged from 
26 to 63 years. It is divided into two groups that correspond in the age, 
15 of them are obese women (BMI >30) their mean age is 44.07±12.52 
years old. On the other hand, there are 15 other women who are 
not obese (BMI<30 their mean age is 44.00±12.03 years old. All the 
volunteers (control and patients) in this study live in the El Oued area 
located in the southeast of Algeria.
Inclusion and exclusion criteria
About inclusion criteria for obesity, we chose women who were 
apparently obese and then confirmed this by calculating the BMI. 
Women who have a BMI >30 were organized for the study.
This means that we selected women with a BMI of <30 and outwardly 
healthy as controls, between 16.66 and 27.18. In our study, we excluded 
pregnant women or women with chronic diseases.
Laboratory investigations 
Blood samples were collected and placed into containing tubes. Blood 
was transferred into EDTA tubes for hematological markers and the 
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serum was obtained after centrifugation. Using a machine named NE 
200 and its Model Nuve at 3000 tour for 5 min, Hematological analysis 
(FNS) is performed by the hematology
Auto analyzer (name: BC – 2800, model: Mindray). As for the rest of the 
analyses biochemical, it is usually performed using Spinreact reactive 
little is used Biomaghreb reactive and appareile of spectrophotomètre 
(name: BA- 88A, model: Mindray) 
Statistical analysis
This study was prepared using MiniTab program. And express the 
results an average Mean±ES (standard deviation). We also GOT p value 
after comparing the average values of the patients with the average of 
the control values whereas the difference gets bigger whenever p<0.05.
RESULTS
Descriptive of study population
The study was conducted in state of El-Oued - the Public Institution for 
Slave Health - Saad Al-Amamrah in Dabila – multi service in Hassani 
Abdul Karim, at the level of the medical laboratory. The number of 
women in our study reached 15 sick women suffering from obesity and 
15 other women who were not obese. The results obtained show that 
there is no significant difference concerning mean age, and the length. 
In contrast to the weight and the BMI, which appear with a very wide 
difference (Table 1).
Biochemical markers
The results obtained showed great agreement on the level of bilirubin 
total in obese and control women, followed by levels of GOT Least 
compatible then levels of GPT, calcium, bilirubin direct. Then the 
cholesterol results (p=0.056) show very little convergence between 
the two groups, because it takes higher levels in patients than for the 
control women and the levels of blood sugar (0.020) and triglycerides 
(0.014) differ between the two groups. And uric acid values are 
completely different (Table 2).
Hematological markers
Our results showed consistent values for total white blood cells, 
followed by levels of monocytes and granulocytes least compatible 
in obese and control women. Then, the total red blood cells results 
(p=0.189), while the values of lymphocytes (p=0.035). It is higher levels 
when obese women. Hemoglobin (p=0.043), mean corpuscular volume 
(MCV) (0.037), and hematocrit (0.049) are shown clear difference 
between obese and control women, where it appears at lower levels 
in obese women. And the most different values are values of platelets 
(p=0.001), it is high in patient women (Table 3).
DISCUSSION
Obesity has emerged as a complex metabolic disease characterized by 
abnormal or excessive fat (BMI≥30 kg/m2) that may adversely affect 
health [12]. This explains the high level of triglycerides obtained in 
the obese women in our study. Cholesterol levels are also high, but 
significant. A large tissue mass needs more energy which was produced 
in addition to secondary products such as free-oxygen radicals, 
central obesity (excessive fat deposition intra-abdominally and in the 
abdominal wall subcutaneous tissue) also causes systemic release of 
adipose-derived inflammatory cytokines, which, in turn, cause oxidative 
stress (OS) and insulin resistance (IR). IR leads to higher circulating 
glucose, which itself increases OS, thus a vicious cycle is set up which 
can result in type 2 diabetes [13-15]. This translates into higher blood 
glucose values for obese women, which increases the risk of developing 
type 2 diabetes. On the other hand, the results showed an increase in 
the level of uric acid in obese women, which may explain the effect of 
this criterion on IR to reduce the urine excretion of uric acid. King et al. 
[16], clinical studies, too, indicate that the sufferer from gout tends to be 
overweight [17]. In addition, the inverse relationship between obesity 
resulting from imbalance in the irregular diet and immunity makes 
obese people more sensitive to infections, which makes them less 
responsive to vaccines [18]. There is also a close relationship between 
adipose tissue and chronic inflammatory processes that may affect 
infection resistance. White adipose tissue (WAT) is usually found at 
higher levels in obese people. Several studies show that WAT has many 
functions, including regulating inflammatory processes. When the body 
has an excess of WAT, chronic inflammation makes it difficult for the 
body to fight infection [19]. Adipocytes and osteoblasts are derived from 
a common multipotential mesenchymal stem cell [20]. White blood 
cell count was elevated in obesity [21], studies have found that, there 
is some sort of association between the increased number of immune 
cells and obesity as a result of a chronic inflammatory condition which 
is created by an increase in the production of cytokines by adipose 
tissue [22]. However, in our study, the white blood cell values did not 
show a significant difference. However, from the average values, we 
can notice their slight increase in the obese compared to the healthy. 
With the exception of monocyte, it showed a significant difference and 
was low in obese people. The induction of cytokines such as Tumor 
necrosis factor-α and interleukin (IL-6) is involved in transcriptional 
reprogramming induced by CIH [23]. On the one hand, it has been 
shown that the administration of IL-6 in the human body increased the 
number of circulating platelets, and on the other hand, obesity has been 
shown not to be associated with increased platelet activation [24]. And 
because obesity means an increase in fat tissue, this means an increase 
in the level of platelets. Study of Sen et al., (2009) conducted that 
increasing tertiles of abdominal height were significantly associated 














Serum Uric acid (mg/l) 26.04±5.74 43.11±11.49 0.000
Serum GOT (UI/l) 32.15±6.85 30.29±6.90 0.330
Serum GPT (UI/l) 31.70±9.72 26.87±11.22 0.118
Serum calcium (mg/l) 83.13±4.24 79.47±8.57 0.120
Serum Bd (mg/l) 0.8493±0.1092 0.7847±0.1718 0.167
Serum Bt (mg/l) 5.149±1.059 5.163±1.036 0.958







Total WBC count (×109/L) 7.37±1.27 7.56±2.39 0.767
Lymphocytes (×109/L) 2.89±0.88 2.493±0.665 0.035
Monocytes (×109/L) 0.09±0.49 0.46±0.10 0.242
Granulocytes (×109/L) 3.98±0.83 4.60±2.02 0.256
Hb (g/dL) 10.39±0.73 9.60±1.38 0.043
Total RBC count (×1012/L) 4.02±0.31 3.86±0.44 0.189
Hematocrit % 34.16±2.29 31.65±4.52 0.049
MCV 85.22±3.71 81.95±5.48 0.037
platelets (×109/L) 229.9±69.5 295±63 0.001
Hb: Hemoglobin, WBC: White blood cells, RBC: Red blood cells, MCV: Mean 
corpuscular volume






The Age 44.00±12.03 44.07±12.52 0.984
Body weight 70.67±8.81 112.13±19.92 0.000
Length 1.5800±0.0672 1.5873±0.0644& 0.666
Body mass index 22.428±3.166 35.27±6.65 0.000
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with increasing levels of mean platelet count in women [25]. About 
50% of total body mass is fat tissue which may stimulate immune cells 
to the innate and adaptive response [26]. When the red blood cell count 
or hemoglobin concentration decreases, anemia results, which affects 
the amount of oxygen in the cells, which affects their energy levels [27]. 
This means that obese women suffer from anemia compared to healthy 
women, p value of hemoglobin levels is 0.043<0.05. This decrease is 
also accompanied by a decrease in the level of values: Hematocrit, MCV, 
although red blood cell values are close between the two groups.
CONCLUSION 
Based on the results obtained during our study and obtained in the 
scientific tribal studies, based on the results we obtained during our 
study and that we obtained in the scientific tribal studies. We can say 
that obesity causes many diseases for women. It is also responsible 
for response immune changes and disturbances of some biochemical 
parameters which can lead to several metabolic diseases.
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